Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jerome Dvonch Insider Profile
4 Followers
Jerome Dvonch, Prinicpal Accounting Officer at NeoGenomics, holds 0.00 shares in NeoGenomics (Ticker: NEO), holds 84.59K shares in Sonoma Pharmaceuticals (Ticker: SNOA). Most recently, Jerome Dvonch ― shares of NeoGenomics on ― for an estimated value of ―.
Jerome Dvonch has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jerome Dvonch holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jerome Dvonch
Jerome Dvonch's Trading History
NeoGenomics
―
Prinicpal Accounting Officer
―
$0.00
Sonoma Pharmaceuticals
Jun 21, 2024
CFO
Uninformative Buy
―
$227.56K
List of latest transactions for each holding click on a transaction to see Jerome Dvonch's performance on stock
You May Also Like
Jerome Dvonch insider profile FAQ
What is the percentage of profitable transactions made by Jerome Dvonch?
The percentage of profitable transactions made by Jerome Dvonch is ―.
What is the average return per transaction made by Jerome Dvonch?
The average return per transaction made by Jerome Dvonch is ―.
What stocks does Jerome Dvonch hold?
Jerome Dvonch holds: NEO, SNOA stocks.
What was Jerome Dvonch’s latest transaction?
Jerome Dvonch latest transaction was an Uninformative Buy of ―.
What was Jerome Dvonch's most profitable transaction?
Jerome Dvonch’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jerome Dvonch's role in NeoGenomics?
Jerome Dvonch's role in NeoGenomics is Prinicpal Accounting Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.